Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Tilray Inc (TLRY)

Tilray Inc (TLRY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,630,462
  • Shares Outstanding, K 133,526
  • Annual Sales, $ 166,980 K
  • Annual Income, $ -321,170 K
  • 60-Month Beta 3.12
  • Price/Sales 11.57
  • Price/Cash Flow N/A
  • Price/Book 13.25
Trade TLRY with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate -0.14
  • Number of Estimates 7
  • High Estimate -0.09
  • Low Estimate -0.19
  • Prior Year -0.62
  • Growth Rate Est. (year over year) +77.42%

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.90 +149.37%
on 12/29/20
22.61 -12.87%
on 01/15/21
+11.83 (+150.32%)
since 12/15/20
3-Month
5.25 +275.24%
on 10/28/20
22.61 -12.87%
on 01/15/21
+14.13 (+253.68%)
since 10/15/20
52-Week
2.43 +710.70%
on 03/18/20
22.95 -14.16%
on 01/21/20
-1.66 (-7.77%)
since 01/15/20

Most Recent Stories

More News
Thinking about trading options or stock in Axon Enterprise, Tilray, Pfizer, Crispr Therapeutics, or General Motors?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AAXN, TLRY, PFE, CRSP, and GM.

AAXN : 150.77 (+0.76%)
CRSP : 199.88 (-4.84%)
TLRY : 19.70 (+6.14%)
GM : 49.97 (-3.03%)
PFE : 36.70 (-0.14%)
Ready for New Cannabis and Psychedelics Boom Ahead: CEOs of Aphria, Icanic Brands, Red Light Holland, and Tilray Discuss New Global Market Opportunities

Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from leaders at: Tilray, Inc. (NASDAQ: TLRY), Icanic Brands (OTC: ICNAF) (CSE:...

TRUFF : 0.2500 (+6.79%)
TRIP.CN : 0.320 (+8.47%)
ICNAF : 0.4945 (+0.92%)
ICAN.CN : 0.630 (+3.28%)
TLRY : 19.70 (+6.14%)
APHA : 12.42 (+2.56%)
3 Marijuana Stocks to Play the Green Rush in 2021

Marijuana stocks are set to be the rage on Wall Street in hopes of legalization in and around the United States, which calls for keeping an eye on the likes of Tilray (TLRY) and Square (SQ).

SQ : 227.75 (-2.17%)
IIPR : 189.30 (-0.25%)
TLRY : 19.70 (+6.14%)
Global Demand for CBD Gummies Could Create a $6.94 Billion Opportunity

Over the next five years, the global CBD gummies market could be worth up to $6.94 billion, according ...

PLPRF : 0.7040 (-1.19%)
CGC : 33.39 (-3.55%)
WEED.TO : 42.49 (-2.79%)
TLRY : 19.70 (+6.14%)
CWEB.TO : 6.10 (+0.66%)
CWBHF : 4.8000 (+0.31%)
YCBD : 3.94 (unch)
CWEB.CN : 19.300 (+1.85%)
PLUS.CN : 0.900 (-1.10%)
Is Tilray (TLRY) Stock Outpacing Its Medical Peers This Year?

Is (TLRY) Outperforming Other Medical Stocks This Year?

TLRY : 19.70 (+6.14%)
The Zacks Analyst Blog Highlights: NVIDIA, JPMorgan, Beazer Homes USA, Tesla and Tilray

The Zacks Analyst Blog Highlights: NVIDIA, JPMorgan, Beazer Homes USA, Tesla and Tilray

JPM : 138.64 (-1.79%)
NVDA : 514.38 (-2.58%)
TSLA : 826.16 (-2.23%)
BZH : 15.37 (-1.28%)
TLRY : 19.70 (+6.14%)
With Growing Demand, the CBD Market Could be Worth $16 Billion by 2025

Fueled by Joe Biden heading to the White House, and an even higher likelihood of more potential legalization ...

CBD-U.TO : 1.86 (+1.09%)
APHA : 12.42 (+2.56%)
CGC : 33.39 (-3.55%)
WEED.TO : 42.49 (-2.79%)
TLRY : 19.70 (+6.14%)
HEXO : 7.21 (+1.12%)
HEXO.TO : 9.19 (+2.00%)
APHA.TO : 15.82 (+3.74%)
This Beverage Opportunity Could be the Next Big Blockbuster for CBD Companies

The global CBD-infused beverage market is expected to jump from about $89 million to more $1.4 billion ...

NBEV : 2.97 (-1.33%)
CGC : 33.39 (-3.55%)
WEED.TO : 42.49 (-2.79%)
WTER : 1.1200 (unch)
TLRY : 19.70 (+6.14%)
WTER.CN : 1.350 (-3.57%)
BEV.CN : 1.090 (+4.81%)
Here're the 5 Top Stock Trades for 2021

We have highlighted stocks worth a look from the five best trading areas of the current year. This includes NVIDIA (NVDA), JPMorgan Chase (JPM), Beazer Homes (BZH), Tesla (TSLA) and Tilray (TLRY).

JPM : 138.64 (-1.79%)
NVDA : 514.38 (-2.58%)
TSLA : 826.16 (-2.23%)
BZH : 15.37 (-1.28%)
TLRY : 19.70 (+6.14%)
Tilray (KL) Looks Good: Stock Adds 5.3% in Session

Tilray (KL) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.

CANF : 1.9000 (+0.53%)
TLRY : 19.70 (+6.14%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strongest short term outlook on maintaining the current direction.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Tilray, Inc. is a pharmaceutical company. It develops cannabis based medicines, drugs, drops and oil products. Tilray, Inc. is based in NANAIMO, Canada.

See More

Key Turning Points

3rd Resistance Point 26.06
2nd Resistance Point 24.33
1st Resistance Point 22.02
Last Price 19.70
1st Support Level 17.98
2nd Support Level 16.25
3rd Support Level 13.94

See More

52-Week High 22.95
Last Price 19.70
Fibonacci 61.8% 15.11
Fibonacci 50% 12.69
Fibonacci 38.2% 10.27
52-Week Low 2.43

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar